{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:17:53Z","timestamp":1778620673828,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18POST33960092"],"award-info":[{"award-number":["18POST33960092"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14SFRN20600009-03"],"award-info":[{"award-number":["14SFRN20600009-03"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.hfc.2019.11.001","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T16:11:04Z","timestamp":1583251864000},"page":"153-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of Common Cardiovascular Emergencies in Critically Ill Patients"],"prefix":"10.1016","volume":"16","author":[{"given":"Yogamaya","family":"Mantha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakushumimarika","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinari","family":"Hieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hfc.2019.11.001_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccc.2014.03.001","article-title":"Cardiogenic shock","volume":"30","author":"Shah","year":"2014","journal-title":"Crit Care Clin"},{"issue":"20","key":"10.1016\/j.hfc.2019.11.001_bib2","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2019.11.001_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.hfc.2019.11.001_bib4","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2014.01.016","article-title":"Inotropes","volume":"63","author":"Francis","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2019.11.001_bib5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study","volume":"41","author":"Felker","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.hfc.2019.11.001_bib6","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","author":"Yancy Clyde","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2019.11.001_bib7","first-page":"437","article-title":"Assessment of the adequacy of oxygen delivery","volume":"22","author":"Mayer","year":"2016","journal-title":"Curr Opin Crit Care"},{"issue":"2","key":"10.1016\/j.hfc.2019.11.001_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15420\/icr.2013.8.2.73","article-title":"Evidence-based management of cardiogenic shock after acute myocardial infarction","volume":"8","author":"Werdan","year":"2013","journal-title":"Interv Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2019.11.001_bib9","first-page":"384","article-title":"Inotropes and vasopressors use in cardiogenic shock: when, which and how much?","volume":"25","author":"Levy","year":"2019","journal-title":"Curr Opin Crit Care"},{"issue":"18","key":"10.1016\/j.hfc.2019.11.001_bib10","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.jacc.2019.02.051","article-title":"Cardiac calcitropes, myotropes, and mitotropes: JACC review topic of the week","volume":"73","author":"Psotka","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2019.11.001_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejheart.2004.07.007","article-title":"Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy","volume":"6","author":"Coletta","year":"2004","journal-title":"Eur J Heart Fail"},{"issue":"9328","key":"10.1016\/j.hfc.2019.11.001_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.hfc.2019.11.001_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease","volume":"118","author":"Overgaard","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2019.11.001_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.hfc.2005.06.013","article-title":"Eosinophilic myocarditis","volume":"1","author":"Ginsberg","year":"2005","journal-title":"Heart Fail Clin"},{"issue":"4","key":"10.1016\/j.hfc.2019.11.001_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.hfc.2018.06.010","article-title":"Current status of inotropes in heart failure","volume":"14","author":"Ginwalla","year":"2018","journal-title":"Heart Fail Clin"},{"issue":"5","key":"10.1016\/j.hfc.2019.11.001_bib16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0735-1097(86)80231-5","article-title":"Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure","volume":"7","author":"Grose","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.hfc.2019.11.001_bib17","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.hfc.2019.11.001_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1074248413489773","article-title":"Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction","volume":"18","author":"Cox","year":"2013","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"21","key":"10.1016\/j.hfc.2019.11.001_bib19","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hfc.2019.11.001_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2019.11.001_bib21","article-title":"Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome","author":"Unverzagt","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.hfc.2019.11.001_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.hfc.2019.11.001_bib23","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study","volume":"107","author":"Dunser","year":"2003","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.hfc.2019.11.001_bib24","first-page":"343","article-title":"Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline","volume":"109","author":"Werdan","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.hfc.2019.11.001_bib25","article-title":"Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome","volume":"1","author":"Schumann","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.hfc.2019.11.001_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jacc.2018.11.036","article-title":"Unloading is not the only question in cardiogenic shock","volume":"73","author":"D\u017eav\u00edk","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2019.11.001_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/pcad.2002.31591","article-title":"Digoxin","volume":"44","author":"Eichhorn","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.hfc.2019.11.001_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.hfc.2019.11.001_bib29","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/CIRCULATIONAHA.105.560110","article-title":"Contemporary use of digoxin in the management of cardiovascular disorders","volume":"113","author":"Gheorghiade","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2019.11.001_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0735-1097(96)00120-9","article-title":"Digoxin reduces cardiac sympathetic activity in severe congestive heart failure","volume":"28","author":"Newton","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2019.11.001_bib31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ars.2015.6376","article-title":"Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress","volume":"23","author":"Daiber","year":"2015","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"10.1016\/j.hfc.2019.11.001_bib32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199802193380807","article-title":"Nitrate therapy for stable angina pectoris","volume":"338","author":"Parker","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.hfc.2019.11.001_bib33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.RES.0000184694.03262.6d","article-title":"Explaining the phenomenon of nitrate tolerance","volume":"97","author":"Munzel","year":"2005","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.hfc.2019.11.001_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002594","article-title":"Trends in 30-day readmission rates for patients hospitalized with heart failure: findings from the get with the guidelines-heart failure registry","volume":"9","author":"Bergethon","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"19","key":"10.1016\/j.hfc.2019.11.001_bib35","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2019.11.001_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hfc.2019.11.001_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.hfc.2019.11.001_bib38","first-page":"256","article-title":"Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches","volume":"1","author":"Koniari","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"2","key":"10.1016\/j.hfc.2019.11.001_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.1994.298","article-title":"Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure","volume":"46","author":"Fliser","year":"1994","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.hfc.2019.11.001_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","article-title":"Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study)","volume":"342","author":"Paterna","year":"2011","journal-title":"Am J Med Sci"},{"issue":"9 Supplement 1","key":"10.1016\/j.hfc.2019.11.001_bib41","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0735-1097(19)32734-2","article-title":"High-dose spironolactone in high risk acute decompensated heart failure: randomized clinical trial","volume":"73","author":"Apriansyah","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2019.11.001_bib42","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hfc.2019.11.001_bib43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCHEARTFAILURE.115.002259","article-title":"Tolvaptan in patients hospitalized with acute heart failure","volume":"8","author":"Felker","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"16","key":"10.1016\/j.hfc.2019.11.001_bib44","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of Tolvaptan, a Vasopressin antagonist, in patients hospitalized with worsening heart failurea randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hfc.2019.11.001_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00059-013-4041-6","article-title":"Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: a meta-analysis of the literature","volume":"40","author":"De Vecchis","year":"2015","journal-title":"Herz"},{"issue":"4","key":"10.1016\/j.hfc.2019.11.001_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/phar.2239","article-title":"Tolvaptan for volume management in heart failure","volume":"39","author":"Gunderson","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.hfc.2019.11.001_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccc.2014.03.006","article-title":"Submassive pulmonary embolism","volume":"30","author":"Busse","year":"2014","journal-title":"Crit Care Clin"},{"issue":"2 Suppl","key":"10.1016\/j.hfc.2019.11.001_bib48","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.hfc.2019.11.001_bib49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2019.11.001_bib50","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1161\/CIR.0000000000000477","article-title":"Management of patients on non-vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting: a scientific statement from the American Heart Association","volume":"135","author":"Raval","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2019.11.001_bib51","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCULATIONAHA.110.961136","article-title":"Management of submassive pulmonary embolism","volume":"122","author":"Piazza","year":"2010","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.hfc.2019.11.001_bib52","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.hfc.2019.11.001_bib53","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.amjcard.2016.01.012","article-title":"Relation of atrial fibrillation in acute myocardial infarction to in-hospital complications and early hospital readmission","volume":"117","author":"Kundu","year":"2016","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2019.11.001_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccc.2014.03.009","article-title":"Managing arrhythmias in the intensive care unit","volume":"30","author":"Tracy","year":"2014","journal-title":"Crit Care Clin"},{"issue":"21","key":"10.1016\/j.hfc.2019.11.001_bib55","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.hfc.2019.11.001_bib56","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2017.10.052","volume":"72","author":"Kusumoto","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2019.11.001_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jccase.2018.09.001","article-title":"Hypertensive emergency presenting with acute spontaneous subdural hematoma","volume":"19","author":"Haddadin","year":"2018","journal-title":"J\u00a0Cardiol cases"},{"issue":"19","key":"10.1016\/j.hfc.2019.11.001_bib58","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJMcp1901117","article-title":"Acute Severe Hypertension","volume":"381","author":"Peixoto","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1016\/j.hfc.2019.11.001_bib59","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in Adults","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2019.11.001_bib60","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ajem.2011.06.040","article-title":"A\u00a0systematic review of nicardipine vs labetalol for the management of hypertensive crises","volume":"30","author":"Peacock","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"10","key":"10.1016\/j.hfc.2019.11.001_bib61","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/oxfordjournals.eurheartj.a061573","article-title":"Evaluation of potential adverse effects of sodium nitroprusside during pacing-induced myocardial ischaemia in man","volume":"5","author":"Ihlen","year":"1984","journal-title":"Eur Heart J"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619301138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619301138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:37:26Z","timestamp":1778618246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713619301138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1551713619301138"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2019.11.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Common Cardiovascular Emergencies in Critically Ill Patients","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2019.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}